Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191788 · ClinicalTrials.gov registry record · NA
Building Recovery By Improving Goals, Habits, and Thoughts
A NA study of Depression and Substance Use, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
- 1
- Study location
NCT01191788: Completed NA study of Depression and Substance Use, sponsored by RAND.
NCT01191788 is a NA study of Depression and Substance Use that has completed, run by RAND. The registered enrollment target is 299 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191788, a NA study of Depression and Substance Use, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will investigate whether group Cognitive Behavioral Therapy (CBT) for depression, with alcohol and other drug (AOD) treatment counselors leading the groups, is effective and cost effective in treating depression. If so, it could substantially increase access to appropriate mental health care. 360 clients with Beck Depression Inventory-II scores \> 17 who are being treated in a single public sector AOD treatment organization will receive one of two conditions: (1) usual care residential AOD treatment (UC); (2) usual care AOD residential treatment plus a 16-session course of group CBT delivered by trained AOD counselors (CBT). Data will be analyzed using an intent-to-treat model. The investigators will collect data on the service-level costs and health effects associated with UC and CBT, and will calculate the incremental cost per unit of depression and AOD improvement, compared to UC.
Primary Outcome
The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Group Cognitive Behavioral Therapy
- BEHAVIORAL Group CBT for Depression
Study Locations (1)
California
- Behavioral Health Services, Inc - Gardena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT01191788 record still lists
NCT01191788 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Group Cognitive Behavioral Therapy is the first listed.
NCT01191788 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01191788 about?
NCT01191788 is a clinical study titled "Building Recovery By Improving Goals, Habits, and Thoughts". The investigators will investigate whether group Cognitive Behavioral Therapy (CBT) for depression, with alcohol and other drug (AOD) treatment counselors leading the groups, is effective and cost effective in treating depression. If so, it could substantially increase access to appropriate mental h...
What is the current status of trial NCT01191788?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2006-08. Estimated completion is 2010-03.
What conditions does trial NCT01191788 study?
This clinical trial studies the following conditions: Depression, Substance Use.
What interventions are being tested in trial NCT01191788?
The interventions under investigation include: Group Cognitive Behavioral Therapy (BEHAVIORAL), Group CBT for Depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT01191788?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01191788 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01191788's enrollment target sits among peer trials
299 148th of 679 higher than 531 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia